Search - tctmd.com

Displaying 161 - 175 of 175

Sort: Relevancy | Date

News Daily News

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Jason Kahn

August 22, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Jason Kahn

June 20, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Conference News

Transradial Primary PCI Lowers Mortality in STEMI Patients

Jason Kahn

May 20, 2011

News Conference News

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Caitlin E. Cox

May 19, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Jason Kahn

May 12, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Daily News

Thrombus Burden May Explain Disadvantage of Facilitated PCI

May 04, 2011

News Daily News

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Jason Kahn

March 31, 2011

News Daily News

CK-MB More Accurate Than Troponin in Identifying Post-PCI MI

January 30, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

Leah Lawrence

January 10, 2011

Advertisement

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Transradial Primary PCI Lowers Mortality in STEMI Patients

POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Thrombus Burden May Explain Disadvantage of Facilitated PCI

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

CK-MB More Accurate Than Troponin in Identifying Post-PCI MI

Higher Long-term Mortality for Women Undergoing Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content